122 related articles for article (PubMed ID: 18323561)
1. Sepsis from liver abscesses in metastatic colorectal carcinoma after chemoimmunotherapy.
Lieuw-a-Fa M; Peringa J; Leeksma O; Terpstra W
J Clin Oncol; 2008 Mar; 26(8):1381-2. PubMed ID: 18323561
[No Abstract] [Full Text] [Related]
2. Neoadjuvant therapy with bevacizumab.
Gruenberger T; Gruenberger B; Scheithauer W
J Clin Oncol; 2006 Jun; 24(16):2592-3; author reply 2593-4. PubMed ID: 16735714
[No Abstract] [Full Text] [Related]
3. Chemotherapy and immunotherapy in metastatic colorectal cancer.
Pohlmann PR; Mernaugh RL; Goff LW
N Engl J Med; 2009 May; 360(20):2134; author reply 2135-6. PubMed ID: 19439750
[No Abstract] [Full Text] [Related]
4. Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.
Mohammed TA; Dennie T; Holen KD
Clin Adv Hematol Oncol; 2011 Jun; 9(6):492-500. PubMed ID: 21841751
[No Abstract] [Full Text] [Related]
5. Chemotherapy and immunotherapy in metastatic colorectal cancer.
Copur MS; Norvell M; Obermiller A
N Engl J Med; 2009 May; 360(20):2135; author reply 2135-6. PubMed ID: 19445033
[No Abstract] [Full Text] [Related]
6. [Chemoembolization of liver metastasis].
Nørgaard H
Ugeskr Laeger; 2012 Mar; 174(12):784. PubMed ID: 22433541
[No Abstract] [Full Text] [Related]
7. Current role of bevacizumab in colorectal cancer.
Saltz L
Clin Adv Hematol Oncol; 2009 Jun; 7(6):375-6. PubMed ID: 19606071
[No Abstract] [Full Text] [Related]
8. [Recent results of irinotecan therapy in colorectal cancer].
Láng I; Hitre E
Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
[TBL] [Abstract][Full Text] [Related]
9. Liver resection after FOLFOX with bevacizumab.
Mickle M; Mulcahy MF
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
[No Abstract] [Full Text] [Related]
10. [Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report].
Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Hasegawa H; Kitagawa Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1834-6. PubMed ID: 24393938
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer.
Karacetin D; Yalcin B; Okten B; Ozturk S; Maral O; Incekara O
J BUON; 2009; 14(4):605-8. PubMed ID: 20148449
[TBL] [Abstract][Full Text] [Related]
12. Practical use of capecitabine plus oxaliplatin (CAPEOX) with bevacizumab for patients with metastatic colorectal cancer that cannot expect conversion therapy.
Yokomizo H; Yoshimatsu K; Otani T; Osawa G; Nakayama M; Matsumoto A; Yano Y; Okayama S; Naritaka Y
Hepatogastroenterology; 2013; 60(128):1911-5. PubMed ID: 24719926
[TBL] [Abstract][Full Text] [Related]
13. 18FDG-PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab-based therapy.
Funaioli C; Pinto C; Di Fabio F; Santini D; Ceccarelli C; De Raffaele E; Fanti S; Castellucci P; Longobardi C; Buggi F; Martoni AA
Tumori; 2007; 93(6):611-5. PubMed ID: 18338499
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study.
Hochster HS; Hart LL; Ramanathan RK; Childs BH; Hainsworth JD; Cohn AL; Wong L; Fehrenbacher L; Abubakr Y; Saif MW; Schwartzberg L; Hedrick E
J Clin Oncol; 2008 Jul; 26(21):3523-9. PubMed ID: 18640933
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab in the treatment of colorectal cancer.
Marshall JL
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):8-9. PubMed ID: 17491585
[No Abstract] [Full Text] [Related]
16. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
Malik Z; Eng C
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
[No Abstract] [Full Text] [Related]
17. Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature.
Sonnenblick A; Meirovitz A
Int J Clin Oncol; 2010 Aug; 15(4):420-2. PubMed ID: 20217448
[TBL] [Abstract][Full Text] [Related]
18. Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view.
Battisti S; Guida FM; Pagliara E; Tonini G; Zobel BB; Santini D
Clin Colorectal Cancer; 2014 Sep; 13(3):e13-5. PubMed ID: 25085312
[No Abstract] [Full Text] [Related]
19. Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver.
Abdalla EK; Eng C; Madary A; Vauthey JN;
Clin Colorectal Cancer; 2006 Mar; 5(6):436-9. PubMed ID: 16635283
[No Abstract] [Full Text] [Related]
20. Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study.
Javle M; Yu J; Garrett C; Pande A; Kuvshinoff B; Litwin A; Phelan J; Gibbs J; Iyer R
Br J Cancer; 2009 Jun; 100(12):1842-5. PubMed ID: 19491904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]